In a report released today, Neil Mehta from Goldman Sachs maintained a Buy rating on Imperial Oil (IMO – Research Report), with a price target of C$79.00. The company’s shares closed last Wednesday at $48.10.
According to TipRanks.com, Mehta is a 5-star analyst with an average return of 15.2% and a 63.3% success rate. Mehta covers the Utilities sector, focusing on stocks such as HF Sinclair Corporation, Par Pacific Holdings, and Marathon Petroleum.
Imperial Oil has an analyst consensus of Hold, with a price target consensus of $57.51, representing a 18.1% upside. In a report issued on June 8, Scotiabank also maintained a Buy rating on the stock with a C$80.00 price target.
The company has a one-year high of $57.89 and a one-year low of $23.94. Currently, Imperial Oil has an average volume of 637.2K.
Based on the recent corporate insider activity of 90 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of IMO in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Imperial Oil Ltd. engages in the provision of integrated oil business. It operates through the following business segments: Upstream, Downstream, Chemical and Corporate and Other. The Upstream segment includes the exploration and production of crude oil, natural gas, synthetic oil, and bitumen. The Downstream segment focuses on refining crude oil into petroleum products. The Chemical segment manufactures and markets hydrocarbon-based chemicals and chemical products. The Corporate and Other segment covers assets and liabilities that do not specifically relate to business segments. The company was founded on September 8, 1880 and is headquartered in Calgary, Canada.
Read More on IMO:
- JMP Securities Keeps Their Hold Rating on Athira Pharma (ATHA)
- Needham Remains a Buy on KVH Industries (KVHI)
- NIO Stock Is Up 30% This Month. Morgan Stanley Sees More Gains Ahead
- Corporation: Repurchase of own shares on 22.06.2022of own shares
- Field Trip Health Ltd. Schedules Fiscal Fourth Quarter and Full Year 2022 Results Conference Call for Thursday, June 30, 2022 at 8:30 AM ET